The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane

Strategies for the development of anticancer drug delivery systems have undergone a dramatic transformation in the last few decades. Lipid-based drug delivery systems, such as a nanostructured lipid carrier (NLC), are one of the systems emerging to improve the outcomes of tumor treatments. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bang, Ki-Hyun, Na, Young-Guk, Huh, Hyun Wook, Hwang, Sung-Joo, Kim, Min-Soo, Kim, Minki, Lee, Hong-Ki, Cho, Cheong-Weon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627627/
https://www.ncbi.nlm.nih.gov/pubmed/31212681
http://dx.doi.org/10.3390/cancers11060807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627627/
https://www.ncbi.nlm.nih.gov/pubmed/31212681
http://dx.doi.org/10.3390/cancers11060807

Ejemplares similares